Hung Sing Li
Impact in
-
- MicroRNA in disease regulation
-
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
-
- COVID-19 Clinical Research Studies 2
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Thomas Yau (6 shared papers)Lui Ng (6 shared papers)Ariel Ka-Man Chow (6 shared papers)Kenrie P. Y. Hui (3 shared papers)Michael C. W. Chan (3 shared papers)Malik Peiris (3 shared papers)John M. Nicholls (2 shared papers)Oswens Siu‐Hung Lo (3 shared papers)
In The Last Decade
Hung Sing Li
13 papers receiving 299 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 48
- Oncology 82
- Biotechnology 26
- Infectious Diseases 51
- Immunology 50
Countries citing papers authored by Hung Sing Li
This map shows the geographic impact of Hung Sing Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hung Sing Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hung Sing Li more than expected).
Fields of papers citing papers by Hung Sing Li
This network shows the impact of papers produced by Hung Sing Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hung Sing Li. The network helps show where Hung Sing Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Hung Sing Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 66 | |
| 2 | 2018 | 41 | |
| 3 | 2015 | 33 | |
| 4 | 2016 | 32 | |
| 5 | 2012 | 28 | |
| 6 | 2021 | 26 | |
| 7 | 2014 | 21 | |
| 8 | 2013 | 17 | |
| 9 | 2015 | 12 | |
| 10 | 2022 | 8 | |
| 11 | 2012 | 8 | |
| 12 | 2015 | 7 | |
| 13 | 2023 | 1 | |
| 14 | 2023 | 0 |
About Hung Sing Li
Hung Sing Li is a scholar working on Infectious Diseases, Molecular Biology, Immunology, Cancer Research and Oncology, having authored 14 papers that have together received 300 indexed citations. Recurring topics across this work include interferon and immune responses (2 papers), COVID-19 Clinical Research Studies (2 papers), Cancer Research and Treatments (2 papers), Influenza Virus Research Studies (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Animal Virus Infections Studies (1 paper) and Lung Cancer Research Studies (1 paper). The work is most often cited by research in Cancer Research (48 citations), Oncology (82 citations), Biotechnology (26 citations), Infectious Diseases (51 citations) and Immunology (50 citations). Hung Sing Li has collaborated with scholars based in Hong Kong and China. Frequent co-authors include Thomas Yau, Lui Ng, Ariel Ka-Man Chow, Kenrie P. Y. Hui, Michael C. W. Chan, Malik Peiris, John M. Nicholls, Oswens Siu‐Hung Lo, Jensen Tung‐Chung Poon and Timothy Ming-Hun Wan. Their work appears in journals such as Antiviral Research, Current Cancer Drug Targets, PLoS ONE, Hepatology and Disease Markers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.